Better Therapeutics Inc (BTTX)

$0.00 0.00 (N/A)
Market Cap 5,000.00
Revenue (ttm) 0.00
Net Income (ttm) -39.76M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -1.44
Volume 4,100
Avg Vol 10,056
Day's Range N/A - N/A
Shares Out 49.86M
Stochastic %K 0%
Beta 0.98
Analysts Strong Buy
Price Target $3.00

Company Profile

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates ar...

Industry: Biotechnology
Sector: Healthcare
Phone: 415 887 2311
Address:
548 Market Street, Suite 49404, San Francisco, United States
walfofwallstreet
walfofwallstreet Oct. 3 at 10:38 PM
After hours fire 🔥List🔥👀👀👀🐺 $ADAP $GPUS $CHR $BURU $BTTX Stay tuned everyone👀👀🐺 All my followers are making bank 🏦 You all gonna be rich 🤑
0 · Reply
WallStVisions
WallStVisions Oct. 3 at 1:06 PM
GIPR is the kind of play that only makes sense before it takes off. Real estate backed. Undervalued. And now with serious whispers of a crypto treasury strategy that could turn this into the next multi-sector rocket. 20x–50x isn’t hype it’s math if they execute. $ZVSA $IMUX $GENE $BTTX $ACXP
0 · Reply
sirspanky
sirspanky Oct. 2 at 2:27 PM
$HCTI — Recurring growth + scale in motion. QuantumNexis on Ezovion has processed 20M and projects 37M in the coming months, with a payment gateway to monetize volume via recurring fees. That’s adoption + a clear take-rate path. At $2.86, the market is still pricing HCTI like there’s no platform leverage. Against small-cap health/telehealth comps, even a conservative EV/Sales band suggests well below fair value while execution improves. What I’m watching next: gateway go-live, regional wins (India/KSA/MY), and continued usage growth. Spec peers to track: $AMWL $ONMD $BTTX #DigitalHealth #AIinHealthcare #RecurringRevenue
0 · Reply
WallStVisions
WallStVisions Sep. 24 at 3:26 PM
XPON has real products, real revenue, and real positioning in energy tech. Lithium supply chain will be in focus all election season. This one has range to $3–5+ on volume alone. $XELA $NBY $BTTX $MNPR $BLIN
0 · Reply
WallStVisions
WallStVisions Sep. 24 at 11:15 AM
XPON - The lithium wave is real XPON is tied directly to it. Energy storage, home power, marine, RV all real-world growth verticals. Float is small. Chart is coiled. The next PR or volume burst could launch it. $NLST $SNSE $ACHL $BTTX $GLSI
0 · Reply
ExecutiveEdge
ExecutiveEdge Sep. 16 at 6:37 PM
MSN has more cash on hand than its entire market cap. No dilution. Zero debt. Golden cross forming. If the chart confirms, $2–$4 isn’t just possible — it’s probable. Most are asleep on this. $PHGE $YOSH $COSM $BTTX $AVTX
2 · Reply
sirspanky
sirspanky Sep. 15 at 9:43 PM
$HCTI Investment Snapshot (~$20M 2025 Potential) 🚀 $HCTI snapshot: ✔️ $15.8M backlog + $2M YTD wins → ~$20M 2025 rev potential ✔️ High-growth sectors: EHR (7% CAGR), Cloud (15%), AI (38%) ✔️ Gross margins: 30–70%+ above industry avg ✔️ Recurring SaaS revenue + global expansion 🌍 Unlike $BTTX & $VERI, $HCTI is early + positioned for profitable growth. 📈🔥 #AI #Cloud #EHR
0 · Reply
Pipelinepivots
Pipelinepivots Sep. 14 at 3:59 AM
MITQ is in prime breakout territory: Golden cross forming, float nearly nonexistent, and no one’s paying attention yet. This setup screams stealth runner. If a headline drops, this won’t move it’ll gap. $INM $OBSV $LGVN $BTTX $AKAN
0 · Reply
sirspanky
sirspanky Aug. 20 at 2:18 PM
$HCTI 💡 While the market keeps selling off, $HCTI is getting pulled into the vortex of exiting liquidity like everything else. But here’s the difference → healthcare IT isn’t cyclical, it’s mission-critical. Compliance, cybersecurity & efficiency solutions don’t vanish in a downturn—they get prioritized. 📉 Politicians can cook the numbers all they want, but let’s be real: we’re already in a recession. And in recessions, hospitals + insurers cut costs by modernizing tech… exactly where HCTI is positioned with CloudEZ, DataEZ & HealthEM.AI. ⚡️ When the dust settles and liquidity rotates back in, undervalued gems like this will bounce harder. $HCTI rockets on small volume, so imagine what happens when real buyers return. Steady hands here win. #AI #Healthcare $TDOC $BTTX
0 · Reply
ExecutiveEdge
ExecutiveEdge Aug. 15 at 8:27 AM
TGL news yesterday & Crypto treasury plays are heating up, and TGL is still hiding under $1 with an intrinsic value near $11. Add a Q3 AI + blockchain product reveal, 2.7M+ users, and a float already turned over multiple times and you have the perfect storm. When this sector runs, TGL could lead it. $XPON $BTTX $ONFO $BTBT $ATNF
0 · Reply
Latest News on BTTX
No data available.
walfofwallstreet
walfofwallstreet Oct. 3 at 10:38 PM
After hours fire 🔥List🔥👀👀👀🐺 $ADAP $GPUS $CHR $BURU $BTTX Stay tuned everyone👀👀🐺 All my followers are making bank 🏦 You all gonna be rich 🤑
0 · Reply
WallStVisions
WallStVisions Oct. 3 at 1:06 PM
GIPR is the kind of play that only makes sense before it takes off. Real estate backed. Undervalued. And now with serious whispers of a crypto treasury strategy that could turn this into the next multi-sector rocket. 20x–50x isn’t hype it’s math if they execute. $ZVSA $IMUX $GENE $BTTX $ACXP
0 · Reply
sirspanky
sirspanky Oct. 2 at 2:27 PM
$HCTI — Recurring growth + scale in motion. QuantumNexis on Ezovion has processed 20M and projects 37M in the coming months, with a payment gateway to monetize volume via recurring fees. That’s adoption + a clear take-rate path. At $2.86, the market is still pricing HCTI like there’s no platform leverage. Against small-cap health/telehealth comps, even a conservative EV/Sales band suggests well below fair value while execution improves. What I’m watching next: gateway go-live, regional wins (India/KSA/MY), and continued usage growth. Spec peers to track: $AMWL $ONMD $BTTX #DigitalHealth #AIinHealthcare #RecurringRevenue
0 · Reply
WallStVisions
WallStVisions Sep. 24 at 3:26 PM
XPON has real products, real revenue, and real positioning in energy tech. Lithium supply chain will be in focus all election season. This one has range to $3–5+ on volume alone. $XELA $NBY $BTTX $MNPR $BLIN
0 · Reply
WallStVisions
WallStVisions Sep. 24 at 11:15 AM
XPON - The lithium wave is real XPON is tied directly to it. Energy storage, home power, marine, RV all real-world growth verticals. Float is small. Chart is coiled. The next PR or volume burst could launch it. $NLST $SNSE $ACHL $BTTX $GLSI
0 · Reply
ExecutiveEdge
ExecutiveEdge Sep. 16 at 6:37 PM
MSN has more cash on hand than its entire market cap. No dilution. Zero debt. Golden cross forming. If the chart confirms, $2–$4 isn’t just possible — it’s probable. Most are asleep on this. $PHGE $YOSH $COSM $BTTX $AVTX
2 · Reply
sirspanky
sirspanky Sep. 15 at 9:43 PM
$HCTI Investment Snapshot (~$20M 2025 Potential) 🚀 $HCTI snapshot: ✔️ $15.8M backlog + $2M YTD wins → ~$20M 2025 rev potential ✔️ High-growth sectors: EHR (7% CAGR), Cloud (15%), AI (38%) ✔️ Gross margins: 30–70%+ above industry avg ✔️ Recurring SaaS revenue + global expansion 🌍 Unlike $BTTX & $VERI, $HCTI is early + positioned for profitable growth. 📈🔥 #AI #Cloud #EHR
0 · Reply
Pipelinepivots
Pipelinepivots Sep. 14 at 3:59 AM
MITQ is in prime breakout territory: Golden cross forming, float nearly nonexistent, and no one’s paying attention yet. This setup screams stealth runner. If a headline drops, this won’t move it’ll gap. $INM $OBSV $LGVN $BTTX $AKAN
0 · Reply
sirspanky
sirspanky Aug. 20 at 2:18 PM
$HCTI 💡 While the market keeps selling off, $HCTI is getting pulled into the vortex of exiting liquidity like everything else. But here’s the difference → healthcare IT isn’t cyclical, it’s mission-critical. Compliance, cybersecurity & efficiency solutions don’t vanish in a downturn—they get prioritized. 📉 Politicians can cook the numbers all they want, but let’s be real: we’re already in a recession. And in recessions, hospitals + insurers cut costs by modernizing tech… exactly where HCTI is positioned with CloudEZ, DataEZ & HealthEM.AI. ⚡️ When the dust settles and liquidity rotates back in, undervalued gems like this will bounce harder. $HCTI rockets on small volume, so imagine what happens when real buyers return. Steady hands here win. #AI #Healthcare $TDOC $BTTX
0 · Reply
ExecutiveEdge
ExecutiveEdge Aug. 15 at 8:27 AM
TGL news yesterday & Crypto treasury plays are heating up, and TGL is still hiding under $1 with an intrinsic value near $11. Add a Q3 AI + blockchain product reveal, 2.7M+ users, and a float already turned over multiple times and you have the perfect storm. When this sector runs, TGL could lead it. $XPON $BTTX $ONFO $BTBT $ATNF
0 · Reply
ExecutiveEdge
ExecutiveEdge Aug. 7 at 5:22 PM
IBG watch this one! Ultra-low float. No dilution. Sitting at the floor with zero resistance above. One PR and this could rip straight through every level. Most will see it after the move. I plan to be in before it. $TMBR $BTTX $PRPH $SNPX
0 · Reply
JamesPuckett120
JamesPuckett120 Jul. 21 at 4:55 PM
$BTTX is bouncing on speculative news, but RMTG is delivering fundamentals—scalable affiliate growth, new territory added, and strong brand control across 21+ countries.
0 · Reply
ExecutiveEdge
ExecutiveEdge Jun. 20 at 2:40 AM
GLMD is the kind of setup traders dream about. No debt. Under cash. Major biotech catalysts coming. Already hit $2.08 with zero PR. The float is thin and the pressure is building. $BTTX $NVOS $SINT $VIRI ….
0 · Reply
KIOUAMINI
KIOUAMINI May. 9 at 9:34 PM
$BTTX , Can some help to update please what happen to bttx stock , have some lost here as well , I see people getting checks? Thank you
0 · Reply
DAKX
DAKX Apr. 5 at 2:48 AM
$BTTX BIG MOVES ON THE HORIZON 🤑🤑🤑
1 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 29 at 9:17 AM
$BTTX Innovative digital health play with FDA-approved diabetes solution. AspyreRx looks promising. Watching closely for commercial traction and potential partnerships. CBT approach could be game-changer for cardiometabolic management. compelling writeup: https://beyondspx.com/article/better-therapeutics-bttx-pioneering-digital-therapeutics-for-cardiometabular-conditions
0 · Reply
Richymike77
Richymike77 Feb. 7 at 5:16 PM
$BTTX the real question! what happens with stock! if anyone has an explanation?!? Thanks
0 · Reply
uglyflint
uglyflint Feb. 5 at 5:15 PM
$BTTX this is dead on fidelity. They should be taking it off the board soon for the graveyard.
0 · Reply
rocklin
rocklin Jan. 2 at 1:26 AM
$BTTX 🫨
0 · Reply
snakecharm
snakecharm Dec. 10 at 8:42 PM
$BTTX Yeah, what's up? I'm crazy rich now!
1 · Reply
DAKX
DAKX Dec. 10 at 8:21 PM
$BTTX MOST ACTION IN MONTHS!! WHO'S SELLING?🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣
0 · Reply
NVDAMillionaire
NVDAMillionaire Dec. 5 at 10:30 AM
$BTTX Better Therapeutics (BTTX): A Pioneering Digital Therapeutics Company Navigating Challenges and Opportunities https://beyondspx.com/article/better-therapeutics-bttx-a-pioneering-digital-therapeutics-company-navigating-challenges-and-opportunities
0 · Reply